ArticleEmerging microbes & infections2023

An mRNA-based broad-spectrum vaccine candidate confers cross-protection against heterosubtypic influenza A viruses.

Feifei Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.